Table 1.
Restoration of the WT Hsp104 (at normal levels) cures most of the spontaneously arising [PSI+] variants
Donor HSP104 genotype and [PSI+] variant (phenotype on 1/2 YPD) | Recipient | Cytoductants | Ade+ cytoductants | % Ade+ | P value |
WT [PSI+1] (ss) | WT | 12 | 11 | 92 | |
WT [PSI+1] (ss) | hsp104T160M | 9 | 9 | 100 | |
WT [PSI+2] (ss) | WT | 12 | 2 | 17 | 6 × 10−5 |
WT [PSI+2] (ss) | hsp104T160M | 16 | 16 | 100 | |
WT [PSI+3] (ss) | WT | 13 | 12 | 92 | |
WT [PSI+3] (ss) | hsp104T160M | 14 | 14 | 100 | |
hsp104T160M [PSI+4] (vwu) | WT | 32 | 13 | 41 | 4 × 10−4 |
hsp104T160M [PSI+4] (vwu) | hsp104T160M | 22 | 21 | 95 | |
hsp104T160M [PSI+5] (vwvu) | WT | 13 | 0 | 0 | |
hsp104T160M [PSI+5] (vwvu) | hsp104T160M | 12 | 0 | 0 | |
hsp104T160M [PSI+6] (vwu) | WT | 21 | 17 | 81 | |
hsp104T160M [PSI+6] (vwu) | hsp104T160M | 15 | 15 | 100 | |
hsp104T160M [PSI+7] (vwu) | WT | 23 | 6 | 26 | 1 × 10−4 |
hsp104T160M [PSI+7] (vwu) | hsp104T160M | 15 | 12 | 80 | |
hsp104T160M [PSI+8] (vwu) | WT | 3 | 0 | 0 | 2 × 10−3 |
hsp104T160M [PSI+8] (vwu) | hsp104T160M | 19 | 19 | 100 | |
hsp104T160M [PSI+9] (vwvu) | WT | 37 | 6 | 16 | 1 × 10−5 |
hsp104T160M [PSI+9] (vwvu) | hsp104T160M | 18 | 15 | 83 | |
hsp104T160M [PSI+10] (vwu) | WT | 28 | 18 | 64 | 1 × 10−5 |
hsp104T160M [PSI+10] (vwu) | hsp104T160M | 21 | 20 | 95 | |
hsp104T160M [PSI+11] (vwvu) | WT | 26 | 7 | 27 | 1 × 10−5 |
hsp104T160M [PSI+11] (vwvu) | hsp104T160M | 14 | 14 | 100 |
The spontaneously arising prion variants isolated in either WT (AG666) or hsp104T160M (AG667) background were used as cytoduction donors to isogenic WT (AG686) or hsp104T160M (AG687) recipients. The cytoduction efficiency of the [PSI+2], [PSI+4], [PSI+7], [PSI+8], [PSI+9], [PSI+10], and [PSI+11] prion variants into hsp104T160M recipients was significantly higher than into WT recipients. ss, strong stable; vwu, very weak unstable; vwvu, very weak very unstable (Fig. S1B). Statistical tests were carried out as described in Methods.